Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles Post author: Post published:April 5, 2024 Post category:uncategorized Recombinant adeno-associated virus (rAAV)-based genetic applications to treat human diseases. You Might Also Like FDA-approved surgical robots trend toward autonomy, study finds April 29, 2024 Epidemiological study of pulmonary tuberculosis in China over six years February 4, 2025 Tiny imaging device could advance gastrointestinal cancer detection February 6, 2024